Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ADUS Stock Forecast 2026-2027
$110.45
Current Price
$2.04B
Market Cap
Buy 12
Hold 1
Sell 1
Wall St Analyst Ratings
Distance to ADUS Price Targets
+44.9%
To High Target of $160.00
+26.8%
To Median Target of $140.00
+5.9%
To Low Target of $117.00
ADUS Price Momentum
-1.7%
1 Week Change
-4.1%
1 Month Change
-15.9%
1 Year Change
+2.8%
Year-to-Date Change
-19.2%
From 52W High of $136.72
+24.2%
From 52W Low of $88.96
📊 TOP ANALYST CALLS
Did ADUS Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Addus HomeCare is one of their latest high-conviction picks.
Latest ADUS Stock Price Targets & Analyst Predictions
Based on our analysis of 20 Wall Street analysts, ADUS has a bullish consensus with a median price target of $140.00 (ranging from $117.00 to $160.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $110.45, the median forecast implies a 26.8% upside. This outlook is supported by 12 Buy, 1 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Andrew Mok at Barclays, suggesting a 5.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ADUS Analyst Ratings
12
Buy
1
Hold
1
Sell
ADUS Price Target Range
Low
$117.00
Average
$140.00
High
$160.00
Current: $110.45
Latest ADUS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ADUS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 13, 2025 | BMO Capital | Sean Dodge | Market Perform | Initiates | $120.00 |
| Nov 7, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $139.00 |
| Nov 5, 2025 | TD Cowen | Ryan Langston | Buy | Maintains | $140.00 |
| Nov 4, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $117.00 |
| Sep 3, 2025 | Stephens & Co. | Raj Kumar | Overweight | Reiterates | $140.00 |
| Sep 2, 2025 | UBS | A.J. Rice | Buy | Initiates | $145.00 |
| Aug 22, 2025 | RBC Capital | Ben Hendrix | Outperform | Maintains | $134.00 |
| Aug 19, 2025 | Barclays | Andrew Mok | Underweight | Maintains | $109.00 |
| Aug 6, 2025 | TD Cowen | Ryan Langston | Buy | Maintains | $139.00 |
| Jul 31, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Jul 16, 2025 | JMP Securities | Constantine Davides | Market Outperform | Reiterates | $150.00 |
| Jun 20, 2025 | JMP Securities | Constantine Davides | Market Outperform | Reiterates | $150.00 |
| Jun 10, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $133.00 |
| May 8, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $133.00 |
| Apr 22, 2025 | JMP Securities | Nicholas Jones | Market Outperform | Reiterates | $150.00 |
| Apr 10, 2025 | JMP Securities | Constantine Davides | Market Outperform | Maintains | $150.00 |
| Mar 12, 2025 | Stephens & Co. | Scott Fidel | Overweight | Reiterates | $142.00 |
| Feb 27, 2025 | Macquarie | Tao Qiu | Outperform | Maintains | $129.00 |
| Feb 26, 2025 | Stephens & Co. | Raj Kumar | Overweight | Maintains | $142.00 |
| Jan 24, 2025 | Oppenheimer | Ari Wald | Outperform | Maintains | $150.00 |
Addus HomeCare Corporation (ADUS) Competitors
The following stocks are similar to Addus HomeCare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ADUS
Addus HomeCare
mkt cap
2.03B
Addus HomeCare Corporation (ADUS) Financial Data
Addus HomeCare Corporation has a market capitalization of $2.04B with a P/E ratio of 23.3x. The company generates $1.35B in trailing twelve-month revenue with a 6.4% profit margin.
Revenue growth is +25.0% quarter-over-quarter, while maintaining an operating margin of +9.5% and return on equity of +8.6%.
Valuation Metrics
Market Cap
$2.04B
Enterprise Value
$2.13B
P/E Ratio
23.3x
PEG Ratio
2.1x
Price/Sales
1.5x
Growth & Margins
Revenue Growth (YoY)
+25.0%
Gross Margin
+32.2%
Operating Margin
+9.5%
Net Margin
+6.4%
EPS Growth
+13.3%
Financial Health
Cash/Price Ratio
+5.1%
Current Ratio
1.7x
Debt/Equity
19.3x
ROE
+8.6%
ROA
+6.9%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Addus HomeCare Corporation (ADUS) Business Model
About Addus HomeCare Corporation
What They Do
Provides home care and support services.
Business Model
The company generates revenue by offering personalized home care services to seniors and individuals with chronic conditions. It partners with Medicaid programs, managed care organizations, and other payers to deliver cost-effective care solutions, ensuring a steady income stream from these collaborations.
Additional Information
Founded in 1979 and headquartered in Frisco, Texas, Addus HomeCare is a significant player in the healthcare sector, poised for growth as the demand for home-based care rises with an aging population. The company expands through strategic acquisitions and organic growth, enhancing its presence in the community-based care industry.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
6,165
CEO
Mr. R. Dirk Allison CPA
Country
United States
IPO Year
2009
Website
www.addus.comAddus HomeCare Corporation (ADUS) Latest News & Analysis
Latest News
Quick Summary
Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH) are key stocks in the Medical - Outpatient and Home Healthcare sector, attracting interest from value investors.
Why It Matters
The comparison of Addus HomeCare and U.S. Physical Therapy highlights potential investment opportunities, guiding value investors in making informed decisions within the outpatient healthcare sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Addus HomeCare (ADUS) has received a Zacks Rank #2 (Buy), indicating growing optimism about its earnings prospects, which may lead to a potential increase in stock value.
Why It Matters
The upgrade to Zacks Rank #2 signals increased confidence in Addus HomeCare's earnings potential, likely attracting more investors and driving the stock price higher.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
COR, ADUS, and SEM receive positive analyst outlooks for 2026, driven by AI adoption, increased home care demand, and facility expansions in the medical sector.
Why It Matters
Bullish analyst support for COR, ADUS, and SEM indicates strong future growth potential due to AI, home care demand, and facility expansion, impacting investment decisions positively.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Investors in Medical - Outpatient and Home Healthcare stocks should consider Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH) for potential value investment opportunities.
Why It Matters
The comparison of Addus HomeCare and U.S. Physical Therapy highlights potential investment opportunities, guiding value investors in selecting stocks with better growth prospects and valuations.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Addus HomeCare (ADUS) is noted for strong growth attributes that may enable it to outperform the market.
Why It Matters
Addus HomeCare's solid growth attributes suggest potential for significant returns, indicating a favorable investment opportunity compared to broader market performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Addus HomeCare Corporation (ADUS) Presents at UBS Global Healthcare Conference 2025 Transcript
2 months ago
Quick Summary
Addus HomeCare Corporation (ADUS) will present at the UBS Global Healthcare Conference on November 12, 2025, at 10:15 AM EST, featuring CEO R. Allison and other key executives.
Why It Matters
Addus HomeCare's participation in the UBS Global Healthcare Conference highlights its visibility and engagement in the healthcare sector, potentially influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About ADUS Stock
What is Addus HomeCare Corporation's (ADUS) stock forecast for 2026?
Based on our analysis of 20 Wall Street analysts, Addus HomeCare Corporation (ADUS) has a median price target of $140.00. The highest price target is $160.00 and the lowest is $117.00.
Is ADUS stock a good investment in 2026?
According to current analyst ratings, ADUS has 12 Buy ratings, 1 Hold ratings, and 1 Sell ratings. The stock is currently trading at $110.45. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ADUS stock?
Wall Street analysts predict ADUS stock could reach $140.00 in the next 12 months. This represents a 26.8% increase from the current price of $110.45. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Addus HomeCare Corporation's business model?
The company generates revenue by offering personalized home care services to seniors and individuals with chronic conditions. It partners with Medicaid programs, managed care organizations, and other payers to deliver cost-effective care solutions, ensuring a steady income stream from these collaborations.
What is the highest forecasted price for ADUS Addus HomeCare Corporation?
The highest price target for ADUS is $160.00 from at , which represents a 44.9% increase from the current price of $110.45.
What is the lowest forecasted price for ADUS Addus HomeCare Corporation?
The lowest price target for ADUS is $117.00 from Andrew Mok at Barclays, which represents a 5.9% increase from the current price of $110.45.
What is the overall ADUS consensus from analysts for Addus HomeCare Corporation?
The overall analyst consensus for ADUS is bullish. Out of 20 Wall Street analysts, 12 rate it as Buy, 1 as Hold, and 1 as Sell, with a median price target of $140.00.
How accurate are ADUS stock price projections?
Stock price projections, including those for Addus HomeCare Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 15, 2026 5:20 AM UTC